| Trial ID: | L6744 |
| Source ID: | NCT01151605
|
| Associated Drug: |
Insulin Infusion
|
| Title: |
The Suppression of Toll Like Receptors by Insulin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Insulin Resistance
|
| Interventions: |
DRUG: insulin infusion|DRUG: Dextrose infusion|DRUG: Saline Infusion
|
| Outcome Measures: |
Primary: The Suppression of Toll Like receptors by Insulin, Expression of TLR2, TLR4, TLR7 and TLR9 mRNA in mononuclear cells and adipose tissue, 24 hours | Secondary: TLR expression, Basal TLR expression in obese and type 2 diabetic subjects as compared to lean subjects, 0 hours
|
| Sponsor/Collaborators: |
Sponsor: University at Buffalo | Collaborators: American Diabetes Association
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-09
|
| Completion Date: |
2013-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-01-05
|
| Locations: |
Millard Fillmore Gates Hospital, Buffalo, New York, 14209, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01151605
|
